Open AccessReview of Trial Therapy and Treatment for COVID-19: Lessons for Indonesia
Author(s) -
Halma Zahro Mukhlida,
Hilma Hasro Maulida,
Gunanti Khairunnisa,
Margaretha Josephine Mantrono,
Risky Kusuma Hartono,
Rindu Rindu,
Eka Rokhmiati Wahyu Purnamasari,
Rizky Fajar Meirawan
Publication year - 2020
Publication title -
kesmas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.146
H-Index - 3
eISSN - 2460-0601
pISSN - 1907-7505
DOI - 10.21109/kesmas.v15i2.3958
Subject(s) - covid-19 , medicine , intensive care medicine , alternative medicine , disease , clinical trial , systematic review , medline , infectious disease (medical specialty) , pathology , outbreak , political science , law
The infectious disease from corona virus, or COVID-19, has quickly spread world-wide since 2019. Therapies for managing COVID-19 have yet to be confirmed as medication for the severe sickness that the disease may cause. This study uses PRISMA guidelines as a method for conducting a systematic literature review. We selected relevant studies published from January 2020 to March 2020 by searching Pubmed, Science Direct and Google Scholar. The research focuses on the treatment of and therapies for COVID-19 only to the patients in the hospital. The inclution 8 articles were screened by using a PRISMA flow after reading 28 abstract and 28 from whole articles. Sixty-seven articles were collected from several online journal databases, and various therapies were found that are effective in the treatment and management of COVID-19. Clinical improvements and Recovery rate have been achieved in a short time compared to standard care only. The findings of the study show that several therapies are effective in managing the severe illness that can be caused by COVID-19. Nevertheless, research into effective therapies for COVID-19 must be continued to find the best therapy and treatment.